5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial A Randomized Comparison of an Early Invasive Versus Selective Invasive Management in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

被引:105
|
作者
Damman, Peter [1 ]
Hirsch, Alexander [1 ]
Windhausen, Fons [1 ]
Tijssen, Jan G. P. [1 ]
de Winter, Robbert J. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Cardiac Catheterizat Lab B2 137, NL-1105 AZ Amsterdam, Netherlands
关键词
NSTE-ACS; treatment strategy; long-term outcomes; TREATMENT STRATEGY; METAANALYSIS;
D O I
10.1016/j.jacc.2009.11.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We present the 5-year clinical outcomes according to treatment strategy with additional risk stratification of the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial. Background Long-term outcomes may be relevant to decide treatment strategy for patients presenting with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and elevated troponin T. Methods We randomly assigned 1,200 patients to an early invasive or selective invasive strategy. The outcomes were the composite of death or myocardial infarction (MI) and its individual components. Risk stratification was performed with the FRISC (Fast Revascularization in InStability in Coronary artery disease) risk score. Results At 5-year follow-up, revascularization rates were 81% in the early invasive and 60% in the selective invasive group. Cumulative death or MI rates were 22.3% and 18.1%, respectively (hazard ratio [HR]: 1.29, 95% confidence interval [CI]: 1.00 to 1.66, p = 0.053). No difference was observed in mortality (HR: 1.13, 95% CI: 0.80 to 1.60, p = 0.49) or MI (HR: 1.24, 95% CI: 0.90 to 1.70, p = 0.20). After risk stratification, no benefit of an early invasive strategy was observed in reducing death or spontaneous MI in any of the risk groups. Conclusions In patients presenting with NSTE-ACS and elevated troponin T, we could not demonstrate a long-term benefit of an early invasive strategy in reducing death or MI. (Invasive versus Conservative Treatment in Unstable coronary Syndromes [ICTUS]; ISRCTN82153174) (J Am Coll Cardiol 2010; 55: 858-64) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:858 / 864
页数:7
相关论文
共 50 条
  • [41] The Prognostic Value of Biomarkers in Non-ST-Elevation Acute Coronary Syndrome Patients that are Treated by an Early Invasive Strategy: Insights from the OPTIMA-2 Trial
    Fagel, Nick D.
    Vink, Maarten A.
    Heestermans, Antonius A. C. M.
    Riezebos, Robert K.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (04)
  • [42] Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology guidelines for the management of patients with non-ST-segment elevation acute coronary syndromes
    Alame, Aya J.
    Karatasakis, Aris
    Karacsonyi, Judit
    Danek, Barbara A.
    Resendes, Erica
    Parachini, Jose R. Martinez
    Kalsaria, Pratik
    Roesle, Michele
    Rangan, Bavana V.
    Sorajja, Paul
    Jneid, Hani
    Banerjee, Subhash
    Brilakis, Emmanouil S.
    CORONARY ARTERY DISEASE, 2017, 28 (04) : 294 - 300
  • [43] Early Versus Delayed Invasive Strategies in High-Risk Non-ST Elevation Acute Coronary Syndrome Patients - A Systematic Literature Review and Meta-Analysis of Randomised Controlled Trials
    Javat, Delara
    Heal, Clare
    Buchholz, Stefan
    Zhang, Zhihua
    HEART LUNG AND CIRCULATION, 2017, 26 (11) : 1142 - 1159
  • [44] Upstream Use of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes A Systematic Overview of Randomized Clinical Trials
    Tricoci, Pierluigi
    Newby, L. Kristin
    Hasselblad, Vic
    Kong, David F.
    Giugliano, Robert P.
    White, Harvey D.
    Theroux, Pierre
    Stone, Gregg W.
    Moliterno, David J.
    Van de Werf, Frans
    Armstrong, Paul W.
    Prabhakaran, Dorairaj
    Rasoul, Saman
    Bolognese, Leonardo
    Durand, Eric
    Braunwald, Eugene
    Califf, Robert M.
    Harrington, Robert A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (04): : 448 - 458
  • [45] The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study
    Nicolau, Jose C.
    Furtado, Remo H. M.
    Baracioli, Luciano M.
    Lara, Livia M.
    Dalcoquio, Talia F.
    Scanavini Junior, Marco A.
    Pereira, Cesar A. C.
    Lima, Viviane M.
    Goncalves, Talita M.
    Colodetti, Raiza
    Ferrari, Aline G.
    Lopes, Renato D.
    Giugliano, Robert P.
    CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (05) : 435 - 442
  • [46] Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines
    Jesús Martinón-Martínez
    Belén Álvarez Álvarez
    Teba González Ferrero
    Federico García-Rodeja Arias
    Óscar Otero García
    Carla Cacho Antonio
    Charigan Abou Jokh Casas
    Pilar Zuazola
    Alberto Cordero
    David Escribano
    Belén Cid Alvarez
    Diego Iglesias Álvarez
    Rosa Agra Bermejo
    Pedro Rigueiro Veloso
    José María García Acuña
    Francisco Gude Sampedro
    José Ramón González Juanatey
    Clinical Research in Cardiology, 2021, 110 : 1464 - 1472
  • [47] Use of Invasive Strategy in Non-ST-Segment Elevation Myocardial Infarction Is a Major Determinant of Improved Long-Term Survival FAST-MI (French Registry of Acute Coronary Syndrome)
    Puymirat, Etienne
    Taldir, Guillaume
    Aissaoui, Nadia
    Lemesle, Gilles
    Lorgis, Luc
    Cuisset, Thomas
    Bourlard, Pierre
    Maillier, Bruno
    Ducrocq, Gregory
    Ferrieres, Jean
    Simon, Tabassome
    Danchin, Nicolas
    JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (09) : 893 - 902
  • [48] Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines
    Martinon-Martinez, Jesus
    Alvarez Alvarez, Belen
    Gonzalez Ferrero, Teba
    Garcia-Rodeja Arias, Federico
    Otero Garcia, Oscar
    Cacho Antonio, Carla
    Abou Jokh Casas, Charigan
    Zuazola, Pilar
    Cordero, Alberto
    Escribano, David
    Cid Alvarez, Belen
    Iglesias Alvarez, Diego
    Agra Bermejo, Rosa
    Rigueiro Veloso, Pedro
    Garcia Acuna, Jose Maria
    Gude Sampedro, Francisco
    Gonzalez Juanatey, Jose Ramon
    CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (09) : 1464 - 1472
  • [49] Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial
    Clemmensen, Peter
    Roe, Matthew T.
    Hochman, Judith S.
    Cyr, Derek D.
    Neely, Megan L.
    McGuire, Darren K.
    Cornel, Jan H.
    Huber, Kurt
    Zamoryakhin, Dmitry
    White, Harvey D.
    Armstrong, Paul W.
    Fox, Keith A. A.
    Prabhakaran, Dorairaj
    Ohman, Erik Magnus
    AMERICAN HEART JOURNAL, 2015, 170 (04) : 695 - +
  • [50] Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial)
    Thiele, Holger
    Rach, Justus
    Klein, Norbert
    Pfeiffer, Dietrich
    Hartmann, Andreas
    Hambrecht, Rainer
    Sick, Peter
    Eitel, Ingo
    Desch, Steffen
    Schuler, Gerhard
    EUROPEAN HEART JOURNAL, 2012, 33 (16) : 2035 - 2043